Skip to main content

Day: October 15, 2020

WESTFIELD KICKS OFF THE HOLIDAY SEASON WITH ‘SHOP YOUR HEART OUT’ EVENT BENEFITTING CHARITIES ACROSS THE U.S.

Los Angeles, CA, Oct. 15, 2020 (GLOBE NEWSWIRE) — Just in time for the start of the holiday shopping season, Westfield announced today a national “Shop Your Heart Out” charitable shopping event to be held at its centers in the U.S. Held October 23 through November 1, guests participating at Westfield destinations will have the chance to donate to their favorite charity to unlock an exclusive offers and discounts from retailers and restaurants such as:– Abercrombie & Fitch, Adidas, Dick’s Sporting Goods, Eataly, Fabletics, H&M, Hollister, Hot Topic, Kiehl’s, MAC Cosmetics, Macy’s, Michael Kors, Neiman Marcus, Pandora, Steve Madden, Shake Shack, Sketchers, Windsor“Westfield is committed to making a significant impact in the local communities we serve, especially during these challenging times,” says Marcus Reese, executive...

Continue reading

First Quantum Minerals Announces Satisfaction of Financing Condition for Senior Notes Redemption

TORONTO, Oct. 15, 2020 (GLOBE NEWSWIRE) — First Quantum Minerals Ltd. (“First Quantum” or “the Company”) (TSX:FM) today announced that, following completion of the issuance of its $1,500 million aggregate principal amount of 6.875% Senior Notes due 2027, the financing condition with respect to the Company’s proposed redemption of its outstanding 7.250% Senior Notes due 2022 (the “2022 Notes”) has been satisfied and the Company will redeem the 2022 Notes in full on October 18, 2020.The information in this announcement does not constitute an offer of securities for sale in the United States or any other jurisdiction. Securities may not be offered or sold in the United States unless they are registered or are exempt from the registration of the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”). The securities referred...

Continue reading

Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients

Mechelen, Belgium and Paris, France, 15 OCTOBER 2020, 22.01 CET; regulated information –Servier and Galapagos NV (Euronext & NASDAQ: GLPG) report that no signal of activity was observed in the topline results in their ROCCELLA Phase 2 trial with GLPG1972/S201086.ROCCELLA is a global, double-blind, placebo-controlled, dose ranging trial evaluating the efficacy and safety of three different once-daily oral doses of GLPG1972/S201086 in 932 patients with knee osteoarthritis (OA) over 52 weeks of treatment. The study population was aged between 40 to 76 years (mean age was 63), mainly female (70%), and with a mean disease duration of 7 years.The primary objective of ROCCELLA was to demonstrate the efficacy of at least one dose of GLPG1972/S201086 compared to placebo after 52 weeks of treatment in reducing cartilage loss of the central medial...

Continue reading

Galapagos en Servier rapporteren topline resultaten van ROCCELLA fase 2-studie met GLPG1972/S201086 bij patiënten met artrose in de knie

Mechelen, België en Parijs, Frankrijk, 15 OKTOBER 2020, 22.01 CET; gereglementeerde informatie – Servier en Galapagos NV (Euronext & NASDAQ: GLPG) melden dat er geen signaal van activiteit werd geobserveerd in de topline resultaten van de ROCCELLA fase 2-studie met GLPG1972/S201086.ROCCELLA is een wereldwijde, dubbelblinde, placebo-gecontroleerde, dosis-variabele studie die de werkzaamheid en veiligheid onderzocht van drie verschillende eenmaal daagse orale doseringen van GLPG1972/S201086 bij 932 patiënten met artrose (osteoartritis; OA) in de knie na 52 weken behandeling. De studiepopulatie was tussen 40 en 76 jaar oud met een gemiddelde leeftijd van 63, voornamelijk vrouwen (70%), en met een gemiddelde ziekteduur van 7 jaar.De primaire onderzoeksdoelstelling van ROCCELLA was om de werkzaamheid aan te tonen van minstens één dosis...

Continue reading

Strata Decision Technology Completes Acquisition of EPSi

Combined Organization Serves 400+ Health Systems, 2,000+ HospitalsCustomer Base of the New Strata Accounts for Approximately 50% of the Hospital and Health System Spend in U.S. HealthcareCHICAGO, Oct. 15, 2020 (GLOBE NEWSWIRE) — Strata Decision Technology (Strata) today announced that it has finalized the acquisition of the EPSi business from Allscripts (NASDAQ: MDRX), creating the gold standard in healthcare for financial analytics, planning and performance solutions. With a combined network of over 400 health systems and 2,000 hospitals and the highest customer satisfaction ratings in the industry for over a decade, the new Strata brings a unique set of software and service solutions to help healthcare providers better analyze, plan and perform in support of caring for their community and reducing the cost of care.Spending on...

Continue reading

Zogenix Presents New Data for FINTEPLA® in Dravet Syndrome at CNS 2020

Interim data from open-label extension trial showed substantial seizure reductions were maintained in patients treated with FINTEPLA® for up to two yearsPost-hoc analysis demonstrated NNTs (Number Needed to Treat) to achieve a clinically meaningful response compared favorably to similar studies of other Dravet syndrome therapiesEMERYVILLE, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) — Zogenix, Inc. (Nasdaq: ZGNX), a global biopharmaceutical company developing rare disease therapies, shared new data analyses for FINTEPLA® (fenfluramine) oral solution in Dravet syndrome at the Child Neurology Society and International Child Neurology Congress (CNS/ICNA) 2020. Dravet syndrome is a rare, highly refractory form of infant- and childhood-onset epilepsy marked by frequent and often prolonged seizures that are difficult to control with existing...

Continue reading

Transocean Ltd. Announces Third Quarter 2020 Earnings Release Date

STEINHAUSEN, Switzerland, Oct. 15, 2020 (GLOBE NEWSWIRE) — Transocean Ltd. (NYSE: RIG) announced today that it will report earnings for the third quarter of 2020, after markets close on Monday, November 2, 2020.The company will conduct a teleconference to discuss the results starting at 9 a.m. EST, 3 p.m. CET, on Tuesday, November 3, 2020. Individuals who wish to participate should dial +1 334-323-0501 and refer to conference code 9072892 approximately 10 minutes prior to the scheduled start time.The teleconference will also be simulcast in a listen-only mode at: www.deepwater.com, by selecting Investors, News, and Webcasts. A replay of the conference call will be available after 12 p.m. EST, 6 p.m. CET, on November 3, 2020. The replay, which will be archived for approximately 30 days, can be accessed at +1 719-457-0820, passcode...

Continue reading

Black Hills Corp. Receives FERC Approval for Wygen I Power Purchase Agreement

RAPID CITY, S.D., Oct. 15, 2020 (GLOBE NEWSWIRE) — Black Hills Corp. (NYSE: BKH) today announced that utility subsidiary Cheyenne Light, Fuel and Power Co., doing business as Black Hills Energy, and power generation subsidiary Black Hills Wyoming received approval of their joint application for a proposed 60-megawatt power purchase agreement from the Federal Energy Regulatory Commission.Under the approved agreement, Black Hills Wyoming will continue to deliver 60 megawatts of base load capacity and energy to Cheyenne Light from its Wygen I power plant. The new agreement will commence on Jan. 1, 2022, replacing the existing power purchase agreement, and will continue for 11 years, ending Dec. 31, 2032. The Wygen I power plant is located near Gillette in northeast Wyoming and is a mine-mouth operation with the adjacent mining complex.“This...

Continue reading

Omega Flex, Inc. Announces Third Quarter 2020 Earnings

EXTON, Pa., Oct. 15, 2020 (GLOBE NEWSWIRE) — Omega Flex today reported its results of operations for the Third Quarter, 2020:Kevin R. Hoben, Chairman and CEO, announced that the Company’s net sales for the first nine months of 2020 and 2019 were $74,171,000 and $81,627,000, respectively, decreasing 9.1%.  Net sales for the three months ended September 30, 2020 were 3.4% lower than the third quarter of 2019.The Company experienced a noticeable deterioration in its sales volume during the second quarter of 2020, as non-essential businesses were closed, most notably residential construction work sites, with April being the trough. Since May, the Company has generally experienced a progressive rise in sales, with multiple periods in excess of 2019.The Company’s net income through September 2020 was $12,732,000 compared to $11,733,000...

Continue reading

Applied Optoelectronics to Announce Third Quarter 2020 Financial Results

SUGAR LAND, Texas, Oct. 15, 2020 (GLOBE NEWSWIRE) — Applied Optoelectronics, Inc. (NASDAQ:AAOI), a leading provider of fiber-optic access network products for the internet datacenter, cable broadband, telecom and fiber-to-the-home (FTTH) markets, today announced that it will release financial results for its third quarter 2020 ended September 30, 2020 on Thursday, November 5, 2020.Applied Optoelectronics will host a conference call and webcast for analysts and investors to discuss its third quarter 2020 financial results and outlook for its fourth quarter 2020 at 4:30 p.m. Eastern Time / 3:30 p.m. Central Time the same day. To participate in the call, please dial 844-890-1794 and ask to be joined to the Applied Optoelectronics call.A live audio webcast of the conference call and supplemental financials will be accessible from the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.